The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Abstract
At the present, medication of dementia is limited to symptomatic treatments such as the use of cholinesterase inhibitors. To cure dementia completely, that is regaining neuronal function, reconstruction of neuronal networks is necessary. Therefore, we have been exploring antidementia drugs based on reconstructing neuronal networks in the damaged brain and found that withanoside IV (a constituent of Ashwagandha; the root of Withania somnifera) induced neurite outgrowth in cultured rat cortical neurons. Oral administration of withanoside IV (10 micromol/kg/day) significantly improved memory deficits in Abeta(25-35)-injected (25 nmol, i.c.v.) mice and prevented loss of axons, dendrites, and synapses. Sominone, an aglycone of withanoside IV, was identified as the main metabolite after oral administration of withanoside IV. Sominone (1 microM) induced axonal and dendritic regeneration and synaptic reconstruction significantly in cultured rat cortical neurons damaged by 10 microM Abeta(25-35). These data suggest that orally administrated withanoside IV may ameliorate neuronal dysfunction in Alzheimer's disease and that the active principle after metabolism is sominone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various CNS active Indian herbal medicines like Withania somnifera, Centella asiatica, Celastrus paniculatus and Bacopa monnieri have shown cognitive improvement in experimental models of AD when given as prophylactic treatment [43,44,45,46,47,48].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Withanoside IV, another chemical constituent of Withania, when administered orally at the dose of 10 micromol/kg prevented cognitive impairment in the experimental model of AD [44].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Sominone (1 microM) a metabolite of Withanoside IV, induced axonal and dendritic regeneration and synaptic reconstruction in cultures of rat cortical neurons damaged by the amyloid peptide, Aβ(25–35) [44].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Withaferin-A extracted from WS (1.882 µg per mouse) could inhibit phorbol-12-myristate 13-acetate (PMA)-induced [Endothelial protein C receptor (EPCR)] shedding by the inhibition of TNF-α and Interleukine (IL)-1b in Human Umbilical Vein Endothelial Cell lines (HUVECs) by inactivating tumor necrosis factor-α converting enzyme (TACE).”
From Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects (2021) · cites this paper as [164]
In the citing paper
“Inhibited TNF-α and IL-1b”
From Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects (2021) · cites this paper as [164]
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530
Reversible memory loss in a mouse transgenic model of Alzheimer’s disease
Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I. M., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–170 of 170
Espallergues, J., Galvan, L., Sabatier, F., Rana-Poussine, V., Maurice, T., & Chatonnet, A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.024 · Cited by 10
Medicinal Plants as Novel Promising Therapeutics for Neuroprotection and Neuroregeneration
Kaur, G., Kataria, H., & Mishra, R. (2018) · Springer eBooks · doi:10.1007/978-981-10-8291-7_20 · Cited by 10
Prakash, H., & Mishra, D. N. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251324377 · Cited by 11
Kaur, A., Kaur, A., & Ohri, P. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19264-1 · Cited by 9
Kuboyama, T., Yang, X., & Tohda, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134665 · Cited by 8
Self-citationPolat, D. Ç., Karadağ, A. E., Köprülü, R. E. P., Karantas, I. D., Mutlu, G., Çağlar, E. Ş., Okur, M. E., Okur, N. Ü., & Siafaka, P. I. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220411104128 · Cited by 7
Naidu, S. A. G., Tripathi, Y. B., Shree, P., Clemens, R., & Naidu, A. S. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.2006388 · Cited by 7
Katiyar, P., Banerjee, S., Nathani, S., & Roy, P. (2022) · Current Research in Toxicology · doi:10.1016/j.crtox.2022.100072 · Cited by 7
In silico evaluation of pharmacokinetics and acute toxicity of withanolides in Ashawagandha
Liu, Y. (2021) · Phytochemistry Letters · doi:10.1016/j.phytol.2021.12.007 · Cited by 6
Nutraceuticals for Cognitive Dysfunction
Gupta, R. C., Doss, R. B., Srivastava, A., Lall, R., & Sinha, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_26 · Cited by 6
Dey, A., Nanda, B., Nandy, S., Mukherjee, A., & Pandey, D. K. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00002-3 · Cited by 6
Mishra, R. N., & Jain, V. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100896 · Cited by 9
Basavan, D., Chalichem, N. S. S., & Mohankumar, S. K. (2018) · Current Drug Targets · doi:10.2174/1389450119666180813095637 · Cited by 5
Neuroactive herbal agents for cognitive dysfunction
Awathale, S. N., Dhoble, L. R., Itankar, P. R., Raut, N. A., & Kokare, D. M. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819489-8.00002-8 · Cited by 5
Sulekha, S. M. P. (2022) · Current Pharmacology Reports · doi:10.1007/s40495-021-00274-5 · Cited by 5
Implications of Herbal Components in the Treatment of Neurological Disorders
Ali, M. D., Verma, S., Malviya, R., Mishra, S., & Sundram, S. (2023) · Current Nutrition & Food Science · doi:10.2174/1573401319666230821102546 · Cited by 6
Antony, B., Aravind, A. P. A., Benny, M., Gupta, N. K., Joseph, B., & Sebastian, A. (2019) · Current Bioactive Compounds · doi:10.2174/1573407215666190308155305 · Cited by 5
Indian Traditional Herbs and Alzheimer’s Disease: Integrating Ethnobotany and Phytotherapy
Malik, J., & Choudhary, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-8127-4_50 · Cited by 5
Therapeutic Effects of Ashwagandha in Brain Aging and Clock Dysfunction
Jagota, A., & Kukkemane, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_21 · Cited by 5
Shukla, S. D. (2025) · Academia Biology · doi:10.20935/acadbiol7925 · Cited by 4
Nobarı, H., Parnian-Khajehdizaj, N., Johnson, K. E., & Ramos-Álvarez, J. J. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01093-5 · Cited by 5
African Traditional Medicine and Potential Role for Mental Health
Lobine, D., & Mahomoodally, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-319-70134-9_124-1 · Cited by 4
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review
Ahmad, S., Ahmad, L., Adil, M., Sharma, R., khan, S., Hasan, N., & Aqil, M. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01863-3 · Cited by 4
Barr, S. A., Davis, L. J., Vidar, W. S., Williamson, R. T., & Strangman, W. K. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c09897 · Cited by 4
Jain, V., Chaturvedi, S., Jamil, S., Tyagi, R., Arya, S., & Madan, S. (2024) · Nutrition & Food Science · doi:10.1108/nfs-01-2024-0030 · Cited by 5
Thalhamer, B., Himmelsbach, M., Schatzmann, B., Klampfl, C. W., & Buchberger, W. W. (2024) · Exploration of Foods and Foodomics · doi:10.37349/eff.2024.00046 · Cited by 4
Combinatory Approaches Targeting Cognitive Impairments and Memory Enhancement: A Review
Kale, P. P., & Gupta, V. S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220928152743 · Cited by 5
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Kuboyama, T. (2018) · Journal of Visualized Experiments · doi:10.3791/58229 · Cited by 4
Self-citationWithania somnifera L. Dunal A potential herb for the treatment of rheumatoid arthritis
Ghawte, S. A., Nikhat, S., Ahmad, J., Mulla, G., & Campus, A. (2014) · Cited by 4
Phytochemical and Therapeutic Potential of Herbal Cognitive Enhancer
Bharti, A., Kashyap, K., Rutika, Moudgil, A., Bora, K. S., & Kumar, D. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/29946 · Cited by 2
Shaikh, A. L., Murray, K. E., Ravindranath, V., & Citron, B. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1368667 · Cited by 3
Clinical applications of Ashwagandha plant in depression and anxiety
Güllü, H., & Kıroğlu, O. (2024) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1460207 · Cited by 4
Exploring Withanolides from Withania somnifera: A Promising Avenue for Alzheimer’s Disease Treatment
Pullaiah, C. P., Preethi Priyadharshini, S. P., Phareedha, S. K., Yamini, N., Birudala, G., Lahari, S., Vippamakula, S., Shakila, R., Ganjayi, M. S., & Raghavendra, M. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00394-2 · Cited by 4
Neuroprotective Potential of Withania Somnifera in Cerebral Ischemia
Raghavan, A. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 3
Experimental evidence to the untapped potential of Ayurvedic herb, Ashwagandha: Bench-to-Bedside
Wadhwa, R., & Kaul, S. C. (2023) · International Journal of Ayurveda Research · doi:10.4103/ijar.ijar_6_23 · Cited by 3
Potential Therapeutic Use of Withania somnifera for Treatment of Amyotrophic Lateral Sclerosis
Dutta, K., Swarup, V., & Julien, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_19 · Cited by 3
Srivastava, A. N., Ahamad, T., Sarfraz, A., Siddiqui, S., Khan, F., Trivedi, A., Khan, M. F., Misra, A., Shankar, H., Khan, M. A., et al. (2026) · Cytoskeleton · doi:10.1002/cm.70131 · Cited by 2
Malhotra, S., & Sandhir, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00013-2 · Cited by 2
Ashwagandha for Brain Health: Experimental Evidence for Its Neuroregenerative Activities
Wadhwa, R., Kalra, R. S., Chaudhary, A., & Kaul, S. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_14 · Cited by 2
Withania somnifera (Ashwagandha) a plant of many possibilities
Czyżewska, I., Jarosz, P. M., & Wiśniewska, P. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.08.053 · Cited by 2
(2008) · Springer eBooks · doi:10.1007/978-3-540-74541-9_7 · Cited by 2
Antioxidants in Alzheimer’s Therapy
Obulesu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816412-9.00003-3 · Cited by 2
Khan, M. S., Zafar, I., & Bopassa, J. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146329 · Cited by 1
Chengappa, K. N. R., Gannon, J. M., Acharya, L., & Rai, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_17 · Cited by 1
Neuromodulatory Role of Withania somnifera
Kaur, G., Kaur, T., Gupta, M., & Manchanda, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_20 · Cited by 1
The Glial Perspective of Energy Homeostasis, Neuroinflammation, and Neuro-nutraceuticals
Sinha, S., Patro, N., & Patro, I. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_23 · Cited by 1
Jindal, D., Pancham, P., Mani, S., Rachana, R., Haider, S., & Singh, M. (2023) · Lecture notes in mechanical engineering · doi:10.1007/978-981-99-3386-0_17 · Cited by 1
Singh, G. (2023) · Springer eBooks · doi:10.1007/978-981-99-2824-8_5 · Cited by 1
Using Human Neural Stem Cells as a Model to Understand the “Science of Ashwagandha”
Tewari, M., Pandey, H. S., & Seth, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_16 · Cited by 1
Cellular and Molecular Targets Underpinning Memory Enhancement by Ashwagandha
Konar, A., & Thakur, M. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_15 · Cited by 1
Neuropharmacology of Withania somnifera Dunal.
Saroya, A. S., & Singh, J. (2018) · Springer eBooks · doi:10.1007/978-981-13-0289-3_16 · Cited by 1
Development of New Therapies for Neurodegenerative Diseases via Axonal Growth
Kuboyama, T. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00147 · Cited by 1
Self-citationReslan, M. A., Issa, H., Al-Haj, N., Ibeh, S., Yehya, Y., Hassan, H. H., Kobeissy, F. H., Eid, A. H., Zibara, K., & Shaito, A. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_15 · Cited by 1
(2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06992-5.00010-4 · Cited by 2
NEUROPROTECTIVE ACTIVITY OF SOME MEDICINAL PLANTS
Shobana, A., Segaran, P., Nesan Kumar, A., & Asokumaran, L. (2015) · International Journal of Pharmacy
African Traditional Medicine and Potential Role for Mental Health
Lobine, D., & Mahomoodally, M. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-57296-9_124
Arellano, E. D. S., Castro-Dionicio, I. Y., Jeyaraj, J. G., Ezzone, N. P. M., & de Blanco, E. J. C. (2023) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-031-26768-0_1
Javed, S., Nazir, A., Zahoor, A. F., & AL‐Huqail, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35403-8_6
Herbal Medicines for Management of Alzheimer’s Disease
Malik, J., Mandal, S. C., Choudhary, S., Parihar, S., & Rahamathulla, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-7703-1_12
Datta, D., & Ghosh, S. (2024) · Journal Of Advanced Zoology · doi:10.53555/jaz.v45i1.4567
Mannich base derivatives in neurological disorders: A comprehensive review with SAR approach
Srivastava, S., Tripathi, A. C., & Yadav, M. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.142669
Raghuvanshi, S., Mazumder, A., & Das, S. (2025) · Journal of Natural Remedies · doi:10.18311/jnr/2025/48646
Dutta, R., Holvoet, H., Marney, L. C., Cabey, K., Neff, C. J., Brandes, M. S., Zweig, J. A., Martinez, J., Choi, J., McClure, C., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120905
Faiqa Sajid, H. A. (2021) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/18.5.231-240 · Cited by 1
Phytomedicinal Approaches to Mitigating Neurological Disorder
Ansari, T., Shukla, R., Shrivastava, S., & Soni, R. K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch015
Li, X., Li, X., Li, Y., Liu, Z., Cai, Y., Yao, Q., Zhao, S., & Yu, Q. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1762061 · Cited by 5
Natural anti-AChE compounds for Alzheimer's disease therapy
Kim, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45844-6.00013-5
Speers, A. B., Limoico, E. D., Lozano-Ortiz, A., Marney, L. C., Choi, J., Barr, S. A., Williamson, R. T., Strangman, W. K., Maier, C. S., & Soumyanath, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125289
PERAN PENGASUHAN ORANG TUA DALAM MEMBENTUK KEMAMPUAN INTERAKSI SOSIAL ANAK DI SLB D YPAC BANDUNG
Akin, K. A. Y. (2026) · Universitas Pasundan institutional repositories & scientific journals (Universitas Pasundan)
Kavitha, J., S., S. K., George, M., Francis, D., & Abi, T. G. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2026.2736169
Metadata
- Authors
- Kuboyama, T., Tohda, C., & Komatsu, K.
- Affiliations
- University of Toyama (JP)
- Corresponding author
- Tohda, Chihiro
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2006-03
- Volume
- 23
- Issue
- 6
- Pages
- 1417-1426
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1841364166
- Cited by
- 171
- References
- 34
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 10 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 15 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- withanoside IV, amyloid beta 25-35, Alzheimer's disease, neurodegeneration, anti-dementia drugs, neurite outgrowth, axon regeneration, memory impairment, Withania somnifera, oral administration, cortical neurons
- MeSH terms
- Animals, Cerebral Cortex, Chromatography, High Pressure Liquid, Ergosterol, Immunohistochemistry, Male, Memory, Nerve Degeneration, Nerve Regeneration, Neurons, Peptide Fragments, Plant Extracts, Mass Spectrometry, Synapses, Amyloid beta-Peptides, Neurites, Rats, Sprague-Dawley, Maze Learning, Withania, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review